PROVE-IT随机对照试验5年结果:机器人对比腹腔镜腹腔内补片腹壁疝修补的患者报告结局
PROVE-IT随机对照试验5年随访显示,腹腔镜IPOM与机器人IPOM在疝相关生活质量、疼痛强度、患者报告膨出、临床复发及再手术率方面均无显著差异。该探索性分析中位临床随访65个月,患者报告结局来自49/75例,临床随访来自64/75例。
要点
- 5年时腹腔镜与机器人IPOM的疝相关生活质量和疼痛评分无显著差异。
- 患者报告膨出率腹腔镜27%、机器人30%,临床复发率10%对24%,均无统计学差异。
- 再手术率两组无显著差异,无补片切除,机器人组无因复发再手术。
核心结论
- 5年随访时腹腔镜与机器人IPOM在生活质量、疼痛、复发和再手术率方面相当。
研究设计与样本
- 基于注册的随机对照试验PROVE-IT的5年随访分析,患者报告结局49/75例(腹腔镜26例,机器人23例),临床随访64/75例(腹腔镜30例,机器人34例)。
主要发现
- 疝相关生活质量中位评分腹腔镜组92(IQR 68,99),机器人组92(IQR 78,95),p=0.91。
- 疼痛强度中位评分两组均为31(IQR 31,31),p=0.86。
- 患者报告膨出率腹腔镜27%,机器人30%,p=1.00。
- 临床复发率腹腔镜10%(n=3),机器人24%(n=8),p=0.27。
临床怎么用
- 对于腹腔内补片腹壁疝修补,腹腔镜与机器人入路在5年患者报告结局和复发再手术方面未见显著差异。
局限性
- 为探索性分析,患者报告结局和临床随访的样本量有限,部分患者失访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Patient-Reported Outcomes of Robotic vs. Laparoscopic Ventral Hernia Repair with Intraperitoneal Mesh (PROVE-IT) randomized controlled trial previously demonstrated comparable pain at 1 year postoperatively between laparoscopic (lapIPOM) and robotic (rIPOM) approaches, although with potential differences in quality of life and recurrence. We aim to report 5-year follow-up of the PROVE-IT trial. METHODS: All patients previously enrolled in PROVE-IT, a registry-based randomized controlled trial published in October 2020, were reviewed. Outcomes including hernia-specific quality of life (Hernia-Related Quality-of-Life Survey [HerQLes]), pain intensity (Patient-Reported Outcomes Measurement Information System [PROMIS 3a]), patient-reported bulging (Hernia Recurrence Inventory [HRI]), clinical hernia recurrences, and reoperations were analyzed. RESULTS: Median time to clinical follow-up was 65 months [interquartile range (IQR) 56, 71]. Patient-reported outcomes were obtained for 49 of 75 patients (26 lapIPOM, 23 rIPOM). Clinical follow-up (physical exam and/or cross-sectional imaging) was completed for 64 of 75 patients (30 lapIPOM, 34 rIPOM). Median HerQLes and PROMIS 3a scores were 92 [IQR 68, 99] and 31 [IQR 31, 31] in the laparoscopic group and 92 [IQR 78, 95] and 31 [IQR 31, 31] in the robotic group (p = 0.91 and p = 0.86, respectively). Patient-reported bulging rates were 27% (lapIPOM) and 30% (rIPOM), p = 1.00. Clinical recurrence rates were 10% (n = 3) in the laparoscopic group and 24% (n = 8) in the robotic group, p = 0.27. Of fourteen abdominal reoperations (8 lapIPOM, 6 rIPOM, p = 0.57), two laparoscopic patients required elective reoperation for recurrence and no patients required mesh excision. There were no reoperations for recurrence in the robotic group. CONCLUSIONS: In this exploratory analysis, postoperative quality of life, pain intensity, recurrence, and reoperation rates were found to be comparable between laparoscopic and robotic IPOMs at 5 years.
引用
- Schmidt EM, Bennett WC, Tocci NX, et al. Five-year outcomes of the PROVE-IT randomized controlled trial: Patient-Reported Outcomes of Robotic vs. Laparoscopic Ventral Hernia Repair with Intraperitoneal Mesh. Surg Endosc. 2026. PMID: 42426391. doi:10.1007/s00464-026-13028-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。